首页> 外文期刊>American Family Physician >Colonoscopy Surveillance After Polypectomy and Colorectal Cancer Resection: CONSENSUS GUIDELINES FROM THE U.S. MULTI-SOCIETY TASK FORCE ON COLORECTAL CANCER and THE AMERICAN CANCER SOCIETY
【24h】

Colonoscopy Surveillance After Polypectomy and Colorectal Cancer Resection: CONSENSUS GUIDELINES FROM THE U.S. MULTI-SOCIETY TASK FORCE ON COLORECTAL CANCER and THE AMERICAN CANCER SOCIETY

机译:息肉切除术和结直肠癌切除术后的结肠镜检查监视:美国关于结肠直肠癌和美国癌症学会的多社会工作队的共识指南

获取原文
获取原文并翻译 | 示例
           

摘要

This article describes a joint update of guidelines by the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer delineating evidence-based surveillance recommendations for patients after polypectomy and colorectal cancer resection. Although there are some qualifying conditions, the following general guidelines apply: after colonoscopic polypectomy, patients with hyperplastic polyps should be considered to have normal colonoscopies, and subsequent colonoscopy is recommended at 10 years. Patients with one or two small (less than 1 cm) tubular adenomas, including those with only low-grade dysplasia, should have their next colonoscopy in five to 10 years. Patients with three to 10 adenomas, any adenoma 1 cm or larger, or any adenoma with villous features or high-grade dysplasia should have their next colonoscopy in three years. Following curative resection of colorectal cancer, patients should undergo a colonoscopy at one year, with subsequent follow-up intervals determined by the results of this examination. Adoption of these guidelines will have a dramatic impact on the quality of care provided to patients after a colorectal cancer diagnosis, will assist in shifting available resources from intensive surveillance to screening, and will ultimately decrease suffering and death related to colorectal cancer. [PUBLICATION ABSTRACT]
机译:本文介绍了美国癌症协会和美国大肠癌多社会工作组联合发布的指南更新,为息肉切除和结直肠癌切除后的患者提供了循证监测建议。尽管有一些符合条件的条件,但应遵循以下一般准则:结肠镜息肉切除术后,增生性息肉患者应被视为结肠镜检查正常,建议在10年后再行结肠镜检查。患有一到两个小(小于1厘米)管状腺瘤的患者,包括仅有轻度不典型增生的患者,应该在5至10年内进行下一次结肠镜检查。患有3至10个腺瘤,任何1厘米或更大的腺瘤,或任何具绒毛特征或高度不典型增生的腺瘤的患者,应在三年内进行下一次结肠镜检查。根治性切除大肠癌后,患者应在一年内接受结肠镜检查,随后的随访间隔由检查结果决定。这些指南的采用将对大肠癌诊断后提供给患者的护理质量产生重大影响,将有助于将可用资源从强化监护转移到筛查,最终将减少与大肠癌相关的痛苦和死亡。 [出版物摘要]

著录项

  • 来源
    《American Family Physician》 |2008年第7期|p.995-1002|共8页
  • 作者单位

    DURADO D. BROOKS, MD, MPH, American Cancer Society, Atlanta, GeorgiaSIDNEY J. WINAWER, MD, Memorial Sloan-Kettering Cancer Center, New York, New YorkDOUGLAS K. REX, MD, Indiana University School of Medicine, Indianapolis, IndianaANN G. ZAUBER, PhD, Memorial Sloan-Kettering Cancer Center, New York, New YorkCHARLES J. KAHI, MD, Indiana University School of Medicine, Indianapolis, IndianaROBERT A. SMITH, PhD, American Cancer Society, Atlanta, GeorgiaBERNARD LEVIN, MD, University of Texas M.D. Anderson Cancer Center, Houston, TexasRICHARD WENDER, MD, Thomas Jefferson University Jefferson Medical College, Philadelphia, PennsylvaniaThe authorsDURADO D. BROOKS, MD, MPH, is the director of prostate and colorectal cancers at the American Cancer Society, Atlanta, Ga.SIDNEY J. WINAWER, MD, is the Paul Sherlock Chair in medicine, gastroenterology, and nutrition services in the Department of Medicine at Memorial Sloan Kettering Cancer Center, New York, NY.DOUGLAS K. REX, MD, is a professor of medicine at Indiana University School of Medicine, Indianapolis.ANN G. ZAUBER, PhD, is an associate attending biostatistician in the Department of Epidemiology and Biostatistics at Memorial Sloan-Kettering Cancer Center.CHARLES J. KAHI, MD, is an assistant professor of medicine in the Division of Gastroenterology and Hepatology at the Richard L. Roudebush VA Medical Center and Indiana University School of Medicine.ROBERT A. SMITH, PhD, is the director of cancer screening at the American Cancer Society.BERNARD LEVIN, MD, is a professor emeritus at the University of Texas M.D. Anderson Cancer Center, Houston.RICHARD WENDER MD, is alumni professor and chair of the Department of Family Medicine at Thomas Jefferson University Jefferson Medical School, Philadelphia, Pa.Address correspondence to Durado D. Brooks, MD, MPH, American Cancer Society, National Home Office, 250 Williams St., Atlanta, GA 30303. Reprints are not available from the authors.Author disclosure: Dr. Rex is on the speakers' bureaus for TAP Pharmaceutical Products, Inc., Novartis, and Olympus America, Inc., the speakers' bureaus and scientific advisory boards for C.B. Fleet Company, and Salix Pharmaceuticals, and the scientific advisory boards for Given Imaging Ltd., Sanofi-Aventis, Neoguide Systems, G. I. View Avantis Medical Systems, American BioOptics, and MGI Pharma, Inc. He has received research support from Olympus America, Inc., C.B. Fleet Company, Salix Pharmaceuticals, G.View Ltd., Given Imaging, and MGI Pharma, Dr. Levin has received research support from G. I. View Ltd. and Pfizer He serves as a consultant to G.View (Israel) and Gene-News (Canada).,;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号